SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-050514
Filing Date
2023-06-21
Accepted
2023-06-21 16:18:45
Documents
1
Period of Report
2023-06-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4079
  Complete submission text file 0001213900-23-050514.txt   5509
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERSARTIS, INC. 1020 MARSH ROAD MENLO PARK CA 94025
Business Address
Shah Vinay (Reporting) CIK: 0001753078 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40064 | Film No.: 231030104